Case Studies

An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...

Recent Blog Posts

February 3, 2012 |

On Tuesday night, PIPC Chairman Tony Coelho joined former HHS Secretary Tommy Thompson at the University of Charleston in West Virginia for a speaker series titled "Who Decides Patient Treatments" to discuss the future of health care in the United States.

| Read More
January 30, 2012 |

PCORI released a draft of their National Priorities for Research and Research Agenda for public comment. The PCORI Board, which is responsible for funding research, is asking for a 55 day public comment period to discuss and solicit feedback from patients, caregivers, professionals, and the general public on the research priorities.

In the draft, PCORI prioritized five broad research areas:

| Read More
October 18, 2011 |

When conducting Comparative Effectiveness Research it is crucial to understand the differences between the players involved in the process. In his remarks at the  2nd Annual Forum on Achieving Patient centeredness , Marc Boutin, executive vice president and COO at the National Health Council, discussed the important differences between the three major players in the process: the patient, the consumer, and the patient advocacy organization. He stated that many times when the patient is discussed they are not defined.

| Read More

For Reporters

For journalists and other media professionals

More Information

Stay Connected

The Issue

Proposals to expand government support for comparative effectiveness research are gaining increased attention in Washington as policy-makers seek ways to improve quality and value in health care. Comparative effectiveness research seeks to learn what works in health care by comparing the patient health outcomes of different health care and treatment options. CER can cover a wide range of health care interventions, from medical tests, treatments and procedures to care management programs, care processes, and benefit designs.

Used appropriately, comparative effectiveness research can play a valuable role in supporting good decision-making in health care. Moreover, improved quality is the best path to greater health care affordability.

It is essential that CER be conducted in a way that promotes improved quality of care and medical progress, preserves patient choice and access to optimal care.

Impact on Patient Access

While CER can play a positive role in improving patient care and health care delivery, it also can be misapplied in ways that unintentionally undermine patient access to care and physician-patient decision-making.

That's because comparative effectiveness research results typically are based on broad population averages that don't reflect the differences in needs of individual patients. Any research results need to be considered along with the broader body of evidence, the patient's individual needs and preferences, and the physician's clinical expertise.

It is important to ensure that CER study results are not misused to impose blunt, "one-size-fits-all" access restrictions.

PIPC Proposes CER Framework

The Partnership to Improve Patient Care's Principles define a framework for CER policy that is centered on improving patient care. With your help, we can make sure these principles are reflected in emerging proposals for government-supported comparative effectiveness research.
Find out more.